Kisa Seymore, MD
Dermatology · Cedartown, GANPI 1841200375
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 28.5% of the total. Reporting peaked in 2019 at $548 and has fallen 50.5% since, to $271 in 2025. That places this record below the midpoint for dermatology clinicians in GA, where the typical reported total is $3,907.
Across 98 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$535
- Novartis$206
- Lilly USA, LLC$177
- Pfizer$152
- Galderma Laboratories, L.p.$143
- Sanofi$124
- plus $543 from 13 others
Across 9 payments — averaging $1770.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$16K
What the payments were for
- Food & beverage$1,74693%
- Education$1347%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $535 |
| Novartis | 15 | $206 |
| Lilly USA, LLC | 9 | $177 |
| Pfizer | 15 | $152 |
| Galderma Laboratories, L.p. | 8 | $143 |
| Sanofi | 5 | $124 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Johnson & Johnson | 1 | $99 |
| Amgen | 3 | $59 |
| Sun Pharmaceutical Industries Inc. | 3 | $51 |
| Boston Scientific | 1 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $40 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $33 |
| VYNE Pharmaceuticals Inc. | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| UCB, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $14 |
How this compares
$1,880 in reported general payments places this provider in the 25th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 46 | $322,810 |
| Cosentyx Unoready PenSecukinumab | 11 | $122,976 |
| Dupixent SyringeDupilumab | 19 | $69,149 |
| Clobetasol Propionate | 113 | $3,874 |
| Tazarotene | 13 | $2,441 |
| Metronidazole | 29 | $1,755 |
| Ketoconazole | 85 | $1,447 |
| Fluorouracil | 20 | $1,444 |
| Clindamycin Phosphate | 34 | $1,183 |
| Triamcinolone Acetonide | 118 | $1,145 |
| Ciclopirox | 25 | $763 |
| Doxycycline Hyclate | 40 | $586 |
| Dapsone | 11 | $495 |
| Cephalexin | 83 | $382 |
| Doxycycline Monohydrate | 16 | $302 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cedartown
- Firas HougeirDouglasville$3.1M
- David CohenMacon$2.9M
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$711K
- Jonathan WeissSnellville$692K
- Jamie WeismanAtlanta$620K
- Mack RachalAtlanta$260K
- Tiffany Clay-RamseyMarietta$207K
- Jessica MercerSnellville$183K
- Sumayah TaliaferroAtlanta$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.